<?xml version="1.0" encoding="UTF-8"?>
<p>Fraction F
 <sub>1</sub> (0.5 g) was subjected to preparative TLC (normal phase) to obtain compound 
 <bold>1</bold> (0.230 g, 
 <xref ref-type="fig" rid="molecules-25-03781-f004">Figure 4</xref>). Fraction F
 <sub>2</sub> (0.5 g) was also subjected to preparative TLC (reversed phase) to obtain fraction F
 <sub>2a</sub> (0.2102 g), an intractable mixture. Fraction F
 <sub>3</sub> (0.5 g) was further purified using semi-preparative HPLC to yield compound 
 <bold>2</bold> (0.019 g). Fraction F
 <sub>4</sub> (0.5 g) was also subjected to preparative TLC (reversed phase) to obtain compound 
 <bold>3</bold> (0.1238 g). F
 <sub>5</sub> (1 g) was further purified using semi-preparative HPLC to obtain compound 
 <bold>4</bold> (0.086 g). Compounds 
 <bold>1</bold> [
 <xref rid="B25-molecules-25-03781" ref-type="bibr">25</xref>], 
 <bold>2</bold> [
 <xref rid="B28-molecules-25-03781" ref-type="bibr">28</xref>], 
 <bold>3</bold> [
 <xref rid="B27-molecules-25-03781" ref-type="bibr">27</xref>], and 
 <bold>4</bold> [
 <xref rid="B27-molecules-25-03781" ref-type="bibr">27</xref>] are known compounds.
</p>
